Filing Details
- Accession Number:
- 0001415889-24-019339
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-08 16:15:11
- Reporting Period:
- 2024-07-03
- Accepted Time:
- 2024-07-08 16:15:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1544227 | Tempest Therapeutics Inc. | TPST | Pharmaceutical Preparations (2834) | 451472564 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1606241 | R Stephen Brady | C/O Tempest Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005 | President And Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-07-03 | 35,000 | $2.11 | 46,376 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 11,376 shares acquired under the Issuer's stock purchase plan.